Drug Type Small molecule drug |
Synonyms LS 001, LS-001, LS001 + [1] |
Target |
Mechanism M4 receptor antagonists(Muscarinic acetylcholine receptor M4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H30ClNO3 |
InChIKeyZTOTXZXWQOUHMG-DDMXTAFESA-N |
CAS Registry869669-27-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 2 | CN | 24 Dec 2021 | |
Parkinson Disease | Phase 2 | CN | 24 Dec 2021 |